Top Markets
Coin of the day
Allena Pharmaceuticals, Inc. Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc.

ALNAQ
Classement en actions #42825
Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on... Operating as a biopharmaceutical firm, Allena Pharmaceuticals, Inc. focuses on unearthing, developing, and marketing oral enzyme therapies. These treatments are devised to assist patients in the United States afflicted by uncommon and serious metabolic as well as renal conditions. Central to its pipeline is ALLN-346, an innovative enzyme designed to degrade urate, targeting hyperuricemia and gout in individuals with advanced chronic kidney disease. The company, which commenced operations in 2011 and has its main office in Newton, Massachusetts, made headlines on September 2, 2022, by seeking voluntary reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Prix de l'action
$0.000001
Dernière synchronisation: 2023-12-13
Capitalisation boursière
$23.51
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Allena Pharmaceuticals, Inc. (ALNAQ)

Catégorie

Historique du rendement du dividende pour Allena Pharmaceuticals, Inc. (ALNAQ)
Le rendement du dividende (TTM) de Allena Pharmaceuticals, Inc. (symbole boursier : ALNAQ) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de Allena Pharmaceuticals, Inc. (ALNAQ) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
Entreprise Rendement du dividende Pays
0.00%
US
0.00%
NL
0.00%
CH
0.65%
BE
0.00%
KR